Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with <i>EGFR</i>-Mutated Non-Small-Cell Lung Cancer.

Chang, Cheng-Yu; Chen, Chung-Yu; Chang, Shih-Chieh; Lai, Yi-Chun; Wei, Yu-Feng

Efficacy and Prognosis of First-Line EGFR-Tyrosine Kinase Inhibitor Treatment in Older Adults Including Poor Performance Status Patients with EGFR-Mutated Non-Small-Cell Lung Cancer.

Chang, Cheng-Yu; Chen, Chung-Yu; Chang, Shih-Chieh; Lai, Yi-Chun; Wei, Yu-Feng.

Afiliación

Chang CY; Division of Chest Medicine, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
Chen CY; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan.
Chang SC; College of Medicine, National Taiwan University, Taipei, Taiwan.
Lai YC; Division of Chest Medicine, Department of Internal Medicine, National Yang-Ming Chiao Tung University Hospital, Yi-Lan, Taiwan.
Wei YF; Faculty of Medicine, College of Medicine, National Yang-Ming Chiao Tung University, Taipei, Taiwan.

Cancer Manag Res ; 13: 7187-7201, 2021.

Article en En | MEDLINE | ID: mdl-34552354

Palabras clave

epidermal growth factor receptor tyrosine kinase inhibitor; non-small-cell lung cancer; older adults; performance status

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Manag Res Año: 2021 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google